Back to today’s briefing

Story perspectives

UK Invests £2.4M in Revolutionary Cancer Blood Test

4/25/2025

50 11

Summary

Story summary

The UK government is investing £2.4 million in the groundbreaking miONCO-Dx blood test, capable of detecting 12 types of cancer, including bowel cancer, with remarkable accuracy exceeding 99%. This innovative AI-powered test analyzes microRNA in blood samples, promising earlier diagnoses and fewer invasive procedures. An NHS clinical trial will engage 8,000 patients to evaluate its impact.

1 of 1

Story summary

The UK government is investing £2.4 million in the groundbreaking miONCO-Dx blood test, capable of detecting 12 types of cancer, including bowel cancer, with remarkable accuracy exceeding 99%. This innovative AI-powered test analyzes microRNA in blood samples, promising earlier diagnoses and fewer invasive procedures. An NHS clinical trial will engage 8,000 patients to evaluate its impact.